Skip to main content

SI-BONE, Inc. (SIBN)

NASDAQ: SIBN · IEX Real-Time Price · USD
22.06 -0.16 (-0.72%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap733.96M
Revenue (ttm)85.15M
Net Income (ttm)-44.68M
Shares Out32.98M
EPS (ttm)-1.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume120,065
Open22.13
Previous Close22.22
Day's Range21.64 - 22.37
52-Week Range19.26 - 37.21
Beta1.43
AnalystsStrong Buy
Price Target38.86 (+76.2%)
Est. Earnings DateNov 8, 2021

About SIBN

SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

IndustryHealth Care Equipment & Supplies
IPO DateOct 17, 2018
CEOJeffrey Dunn
Employees295
Stock ExchangeNASDAQ
Ticker SymbolSIBN
Full Company Profile

Financial Performance

In 2020, SI-BONE, Inc.'s revenue was $73.39 million, an increase of 9.04% compared to the previous year's $67.30 million. Losses were -$43.70 million, 13.8% more than in 2019.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for SI-BONE, Inc. stock is "Strong Buy." The 12-month stock price forecast is 38.86, which is an increase of 76.16% from the latest price.

Price Target
$38.86
(76.16% upside)
Analyst Consensus: Strong Buy

News

SI-BONE To Report Third Quarter 2021 Financial Results on November 8, 2021

SANTA CLARA, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced i...

4 days ago - GlobeNewsWire

SI-BONE, Inc. Announces UnitedHealthcare Adopts Exclusive iFuse Only Coverage for Minimally Invasive SI Joint Fusion

The transition to an exclusive triangular implant policy by UnitedHealthcare, the nation's largest health insurer, is supported by over 100+ peer-reviewed publications, and comes as SI-BONE surpasses 60...

1 week ago - GlobeNewsWire

SI-BONE to Participate in Upcoming Conferences

SANTA CLARA, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced t...

1 month ago - GlobeNewsWire

SI-BONE Q2 Sales Beat Estimates But Higher Costs Hit Profitability, Maintains FY21 Revenue Outlook

SI-BONE Inc (NASDAQ: SIBN) reported Q2 sales of $22.2 million, beating the consensus of $21.96 million, representing a 58% Y/Y increase over the COVID-19 impacted 2020 period. U.S. revenue of $20.2 mill...

2 months ago - Benzinga

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of -7.69% and 0.77%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SI-BONE: Q2 Earnings Insights

Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 4.55% over the past year to ($0.42), which missed ...

2 months ago - Benzinga

SI-BONE, Inc. Reports Second Quarter 2021 Financial Results and Announces Exclusive Coverage from Anthem

Record Second Quarter 2021 Worldwide Revenue of $22.2 million Record Second Quarter 2021 Worldwide Revenue of $22.2 million

2 months ago - GlobeNewsWire

SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangul...

Anthem is America's 2nd largest commercial health insurer and joins more than 35 other health plans to offer coverage exclusively for the triangular iFuse Implant System Anthem is America's 2nd largest ...

2 months ago - GlobeNewsWire

Si-Bone (SIBN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SI-BONE To Report Second Quarter 2021 Financial Results on August 2, 2021

SANTA CLARA, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced i...

3 months ago - GlobeNewsWire

SI-BONE, Inc. Announces Centene Establishes Positive Coverage for MIS SI Joint Fusion including the Triangular iFuse ...

New positive coverage policy provides access to iFuse as an important treatment option for patients with chronic sacroiliac joint pain and dysfunction New positive coverage policy provides access to iFu...

3 months ago - GlobeNewsWire

SI-BONE's Sacroiliac Joint Implant Show Accelerated Fusion, Reduction In Opioid Use

SI-BONE Inc (NASDAQ: SIBN) has announced the publication of 2-year results from the SALLY study of the iFuse-3D Implant System.  Clinical results at 24 months showed marked and sustained improvements in...

3 months ago - Benzinga

SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate ...

There are now 95 peer-reviewed publications demonstrating the safety, effectiveness, biomechanical or economic benefits of iFuse Technology™ There are now 95 peer-reviewed publications demonstrating the...

3 months ago - GlobeNewsWire

SI-BONE, Inc. Announces the Introduction of the SI-BONE SImulator™ Powered by Medability for iFuse Surgeon Training a...

SANTA CLARA, Calif., July 02, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anat...

3 months ago - GlobeNewsWire

French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.'s iFuse-3D Implant System™

Exclusive Coverage Takes Effect June 1, 2021, and Extends for 5 Years Exclusive Coverage Takes Effect June 1, 2021, and Extends for 5 Years

4 months ago - GlobeNewsWire

SI-BONE to Present at the 2021 JMP Securities Life Sciences Conference

SANTA CLARA, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced t...

4 months ago - GlobeNewsWire

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of 2.63% and 7.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Recap: SI-BONE Q1 Earnings

Shares of SI-BONE (NASDAQ:SIBN) remained quited after the company reported Q1 results. Quarterly Results Earnings per share were up 21.28% year over year to ($0.37), which beat the estimate of ($0.39).

5 months ago - Benzinga

SI-BONE, Inc. Reports First Quarter 2021 Financial Results and Reiterates 2021 Financial Guidance

SANTA CLARA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fina...

5 months ago - GlobeNewsWire

SI-BONE to Present at the 7th Annual Truist 2021 Life Sciences Summit and the 2021 Bank of America Health Care Confer...

SANTA CLARA, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

6 months ago - GlobeNewsWire

SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of Helen Loh and Laura Franc...

SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ana...

6 months ago - GlobeNewsWire

SI-BONE To Report First Quarter 2021 Financial Results on May 3, 2021

SANTA CLARA, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

6 months ago - GlobeNewsWire

Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of 6.67% and 0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Recap: SI-BONE Q4 Earnings

Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 22.22% year over year to ($0.28), which beat the estima...

7 months ago - Benzinga

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Issues 2021 Financial Guidance

SANTA CLARA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fi...

7 months ago - GlobeNewsWire